BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30935840)

  • 1. The impact of cystic fibrosis-related diabetes on health-related quality of life.
    Kwong E; Desai S; Chong L; Lee K; Zheng J; Wilcox PG; Quon BS
    J Cyst Fibros; 2019 Sep; 18(5):734-736. PubMed ID: 30935840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The course of glucose intolerance in children with cystic fibrosis: a retrospective study - preliminary report.
    Piechowiak K; Trippenbach-Dulska H; Walicka-Serzysko K
    Dev Period Med; 2015; 19(1):80-91. PubMed ID: 26003073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CF-related diabetes: Containing the metabolic miscreant of cystic fibrosis.
    Moheet A; Moran A
    Pediatr Pulmonol; 2017 Nov; 52(S48):S37-S43. PubMed ID: 28714601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity and specificity of different methods for cystic fibrosis-related diabetes screening: is the oral glucose tolerance test still the standard?
    Mainguy C; Bellon G; Delaup V; Ginoux T; Kassai-Koupai B; Mazur S; Rabilloud M; Remontet L; Reix P
    J Pediatr Endocrinol Metab; 2017 Jan; 30(1):27-35. PubMed ID: 27977404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis.
    Rafii M; Chapman K; Stewart C; Kelly E; Hanna A; Wilson DC; Tullis E; Pencharz PB
    Am J Clin Nutr; 2005 Feb; 81(2):421-6. PubMed ID: 15699230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological management of cystic fibrosis related diabetes.
    Moheet A; Moran A
    Expert Rev Clin Pharmacol; 2018 Feb; 11(2):185-191. PubMed ID: 29268054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of glucose intolerance in cystic fibrosis.
    Mohan K; Miller H; Dyce P; Grainger R; Hughes R; Vora J; Ledson M; Walshaw M
    Diabet Med; 2009 Jun; 26(6):582-8. PubMed ID: 19538232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose intolerance in cystic fibrosis patients.
    Lanng S
    Paediatr Respir Rev; 2001 Sep; 2(3):253-9. PubMed ID: 12052327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis].
    Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R
    Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relationship between insulin secretion, the insulin-like growth factor axis and growth in children with cystic fibrosis.
    Ripa P; Robertson I; Cowley D; Harris M; Masters IB; Cotterill AM
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):383-9. PubMed ID: 11940051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes in cystic fibrosis.
    Bridges N
    Paediatr Respir Rev; 2013 May; 14 Suppl 1():16-8. PubMed ID: 23522600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral glucose tolerance test and continuous glucose monitoring to assess diabetes development in cystic fibrosis patients.
    Clemente León M; Bilbao Gassó L; Moreno-Galdó A; Campos Martorrell A; Gartner Tizzano S; Yeste Fernández D; Carrascosa Lezcano A
    Endocrinol Diabetes Nutr (Engl Ed); 2018 Jan; 65(1):45-51. PubMed ID: 29137964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cystic fibrosis related diabetes mellitus - diagnostic and management challenges.
    Lek N; Acerini CL
    Curr Diabetes Rev; 2010 Jan; 6(1):9-16. PubMed ID: 20034372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress and cystic fibrosis-related diabetes: a pilot study in children.
    Ntimbane T; Krishnamoorthy P; Huot C; Legault L; Jacob SV; Brunet S; Levy E; Guéraud F; Lands LC; Comte B
    J Cyst Fibros; 2008 Sep; 7(5):373-84. PubMed ID: 18420468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetes mellitus in patients with cystic fibrosis.
    Alves Cde A; Aguiar RA; Alves AC; Santana MA
    J Bras Pneumol; 2007; 33(2):213-21. PubMed ID: 17724542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and treatment of cystic fibrosis-related diabetes. A survey of current medical practice in the U.S.
    Allen HF; Gay EC; Klingensmith GJ; Hamman RF
    Diabetes Care; 1998 Jun; 21(6):943-8. PubMed ID: 9614612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetes and Prediabetes in Children With Cystic Fibrosis: A Systematic Review of the Literature and Recommendations of the Italian Society for Pediatric Endocrinology and Diabetes (ISPED).
    Mozzillo E; Franceschi R; Piona C; Passanisi S; Casertano A; Pjetraj D; Maltoni G; Calcaterra V; Cauvin V; Cherubini V; D'Annunzio G; Franzese A; Frongia AP; Lombardo F; Lo Presti D; Matteoli MC; Piccinno E; Predieri B; Rabbone I; Scaramuzza AE; Toni S; Zucchini S; Maffeis C; Schiaffini R
    Front Endocrinol (Lausanne); 2021; 12():673539. PubMed ID: 34017312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical importance of cystic fibrosis-related diabetes.
    Brennan AL; Geddes DM; Gyi KM; Baker EH
    J Cyst Fibros; 2004 Dec; 3(4):209-22. PubMed ID: 15698938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New Concepts in the Pathogenesis of Cystic Fibrosis-Related Diabetes.
    Moheet A; Moran A
    J Clin Endocrinol Metab; 2022 May; 107(6):1503-1509. PubMed ID: 35106591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of insulin secretion indices in cystic fibrosis patients.
    Hammana I; Potvin S; Tardif A; Berthiaume Y; Coderre L; Rabasa-Lhoret R
    J Cyst Fibros; 2009 Dec; 8(6):378-81. PubMed ID: 19782008
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.